Ascend Laboratories Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules Due to the Detection of NDMA Impurity

The product is used as an oral anticoagulant to lower the risk of stroke and blood clots 

Related Keywords

United States ,Dabigatran Etexilate ,Contact Center ,Drug Administration ,Ascend Laboratories ,Dabigatran Etcxilate ,Acceptable Daily Intake ,Packaging Configuration ,Dabigatran Etexilate Capsules ,Watch Adverse Event Reporting ,